Pharma's Almanac is excited to meet the following companies on our journey to discuss the next big thing in pharma. Thank you for your time and for sharing your valuable knowledge and insights.
SanaClis is a full-service Global CRO with a fully integrated clinical supply chain, including a portfolio of GMP/GDP certified storage and distribution depots, in addition to offering a comprehensive range of end-to-end services for clinical trials. SanaClis has vast experience of successfully conducting studies for various sized sponsors, ranging from virtual biotech’s to top ten pharma companies, both in terms of its CRO and Clinical supply services.
Avid Bioservices, Inc. (NASDAQ: CDMO) is a dedicated commercial biologics CDMO, located in Southern California, USA, focused on the development and CGMP manufacture of biopharmaceuticals derived from mammalian cell culture. The company has manufactured commercial biologics since 2005, has more than 27 years of expertise in mammalian cell culture development and manufacturing of complex biologics, and has produced more than 150 commercial batches of drug substances. From concept to commercialization, Avid is your trusted partner for quality biologics.
BIOVECTRA is a forward-thinking, North American contract development and manufacturing organization (CDMO) with full-service, clinical-to-commercial scale GMP outsourcing solutions for critical raw materials, intermediates, active pharmaceutical ingredients, and biologic drug substances. An innovative and reliable partner with a strong regulatory history and commercial supply experience, BIOVECTRA has a 50-year track record of delivering: synthetic small molecules, fermented small molecules, highly potent APIs, biologics, and bioreagents.
Federal Equipment Company has over 60 years of experience buying and selling used equipment focusing on pharmaceutical processing, including API manufacturing, oral solid dose, sterile equipment, and more. The company also facilitates auctions on a global scale, helping sellers to liquidate a broader range of inventory and maximize value. The company's unique position enables fast turnaround, expert service, and competitive cost management, along with expert equipment training and troubleshooting.
Globyz Biopharma Services is dedicated to sourcing and supplying commercial medicines for analytical research, drug development, clinical trials, or bioequivalence studies across all therapeutic areas. Based on years of experience, Globyz Biopharma Services possesses strong expertise in managing the regulatory, logistics, and supply chain challenges of sourcing, storing, and distributing pharmaceuticals for clinical trials. Globyz has an international presence, with GMP depots strategically located in the United States, Canada, Germany, India, Singapore, and Brazil, and is expanding its global footprint to meet the growing demand for clinical supply services.
Grifols Partnership is a contract development and manufacturing platform (CDMO) focused on added value injectable products (small molecules), mainly in flexible bags, with large international experience in the development and manufacturing of many types of sterile drug products. The company is able to leverage the resources and experiences of the larger Grifols organization to provide significant value to partners. Customers who have chosen Grifols as CDMO range from local, medium-sized pharmaceutical companies, to global industry leaders, in the human and veterinary sectors. Grifols Partnership belongs to Grifols a global healthcare company whose mission is to improve the health and well-being of patients around the world. They are industry leaders producing plasma-derived medicines and transfusion medicine organized into four divisions: Bioscience, Diagnostic, Hospital, and Bio Supplies.
IDT Biologika is a global biopharmaceutical contract development and manufacturing organization that specializes in the production of innovative live viral vaccines, viral vectors for gene & immune therapeutics, oncolytic viruses and virus-like particles to improve human health worldwide. The company offer clients a single source contract partner at our sites in the USA and Germany, with seamless end-to-end solutions and the ability to nimbly scale projects from process development through to clinical and commercial batches.
Integrated Project Services, LLC is a full-service AEC firm dedicated to helping clients improve operations and succeed with capital projects. The company specializes in complex facilities in hi-tech and highly regulated industries, including the life sciences, providing knowledge, skill, and passion in the areas of technical consulting, project controls, design and engineering, construction, commissioning, qualification, and validation.
Experience The Smoothest Path to Clinic. Scorpion Biological Services is an integrated contract research, and contract development and manufacturing organization (CDMO) focused on cell- and gene-based therapies and large molecule biologics. We provide a broad portfolio of R&D, analytical and manufacturing services to academic labs, research institutes, pharma companies and biotechs.
Tapemark is a full-service CDMO specializing in the innovation of transdermal, oral thin film, and unit dose semi-solid drug delivery. Working with hundreds of clients from around the globe, Tapemark is proud to partner with pharmaceutical makes of every shape and size.
ABS is a leading provider of laboratory technologies and services needed by mature and emerging markets. They're a single source of manufacturer-agnostic expertise and have a long history of innovation that enables our clients’ innovations. Solutions include exceptional lab equipment, impartial consulting, and highly responsive, world-class technical service.
Arranta Bio is a visionary contract development and manufacturing organization (CDMO) that partners with companies seeking to develop and manufacture complex biological drugs and innovative therapies. Arranta Bio continues to expand capacity and development and manufacturing services across multiple sites with technology platforms designed to meet the evolving demands of our clients and partners.
Dynamk Capital is a venture capital and growth equity firm focused on Life Sciences Industrials. Dynamk's investment strategy is centered on identifying companies developing disruptive technologies, tools, and services that enable the full biopharma continuum across discovery, development, and manufacturing of biotherapeutics, including cell & gene therapies, and vaccines. The Dynamk team of experienced life science entrepreneurs, investors, advisors, and subject matter experts provides capital and strategic advice to entrepreneurs commercializing innovative life science technologies.
With a purpose-driven culture and innovation at its core, Inceptor Bio is committed to advancing gene and cell therapies to confront one of humanity’s single most complex problems — difficult-to-cure cancers. They strive to enable patients to realize what was once an impossible dream — to be cured.
Kineticos Life Sciences is a life sciences consulting firm with a depth of expertise driving strategy and growth for clients. Their consultancy focuses on oncology, cell and gene therapy, and other advanced therapeutics. Kineticos delivers strategy and growth through a process of primary research among a proprietary network of subject matter experts and a large database of segment key opinion leaders, which serves as the foundation of insights that support recommendations.
Rentschler BioPharma is a leading global CDMO, focused exclusively on client projects. From their headquarters in Laupheim, Germany, and their site in Milford, MA, USA, they offer end-to-end solutions including biopharmaceutical process development and manufacturing as well as related consulting activities such as project management and regulatory support.
Market leaders in multiple industries, including life sciences, look to the Secant Group as their integrated supplier for next-generation biomaterials, technical materials, textile engineering, and process technologies. They work closely with their sister companies, SanaVita Medical and Charter Medical, to provide essential products and services to life science companies. Through integrated research and development activities, they help bring new technologies and therapies to market.
Olon Group is a global leader in the development and production of active pharmaceutical ingredients for CDMO and Generics, a reliable and preferential partner to the pharmaceutical, biotech, and specialty ingredients markets.
aCGT Vector is an international Cell Therapy GMP-in-a-POD manufacturing platform business that is working to increase patient access to precision personalized medicine by enabling a network of hospital centres of cancer excellence. Our goal is deployment of cell therapy procedures proximal to patients, eliminating logistical complexity and risk using hospital co-located manufacturing technology platforms. A next-generation hospital-based cell therapy procedure company, our core aim is to bring promise to the 350 million patients suffering from over 7,000 rare diseases around the world through delivery of procedures across its network of hospital-based GMP-in-a-POD Cell Therapy centres.
For over 75 years, Alconox Inc. has met the global critical cleaning needs of scientists and engineers by supplying American-made, high-quality detergents with expert technical support. Alconox manufactures and markets detergents for hard surface cleaning applications where critical cleaning is essential. As a recognized leader in laboratory and processing scale detergents, the company’s products are sold in over 50 countries worldwide and used extensively in the pharmaceutical, biotech, medical device, healthcare, electronics, cosmetics, solar, food, nuclear, optics, and hosts of other industries.
Many patients would not be able to complete their childhood without the life-changing therapies in development at Andelyn Biosciences, a global CDMO. By manufacturing gene therapies for clients worldwide, Andelyn is pioneering solutions that turn hope into reality for families looking for a healthy future. Our innovative manufacturing capabilities are paired with our clients’ life-changing research. Therapies for incurable diseases and rare disorders are the result.
DPS Group is a global engineering, consulting, and project management company serving high-tech industries worldwide for over 46 years. DPS delivers services for clients across the complete engineering and construction value chain, including feasibility studies, concepts, consulting, architecture, engineering, procurement, construction management, commissioning, qualification, and validation, as well as contingent staffing solutions.
MilliporeSigma's purpose is to solve the toughest problems in life science by collaborating with the global scientific community – and, through that, accelerate access to better health for people everywhere. The company provides scientists and engineers with best-in-class lab materials, technologies, and services and is dedicated to making research and biotech production simpler, faster, and safer.
The Montana BioScience Alliance serves as a hub for Montana’s biotechnology companies, entrepreneurs, laboratories, hospitals, clinics, and universities to commercialize, grow, and sustain globally competitive bioscience enterprises – ultimately to create high-quality jobs and economic opportunities in Montana.
21159 Pharma is a Pharmaceutical Business Development company focused on product in-license and out- licensing and providing BD support for CMC outsourcing of all aspects of the drug development process.
AGC Biologics is a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) offering end-to-end services. We develop and manufacture mammalian and microbial-based therapeutic proteins, recombinant DNA, plasmid DNA, viral vectors and genetically engineered cells. Our global network of sites across three continents and more than 2,000 employees help us offer customized services for the development, scale-up and GMP manufacturing of protein-based therapeutics, from pre-clinical to commercial production.
AIHA is the association for scientists and professionals committed to preserving and ensuring occupational and environmental health and safety (OEHS) in the workplace and community. Founded in 1939, they support members with expertise, networks, comprehensive education programs, and other products and services that help maintain the highest professional and competency standards.
AIS Healthcare goes beyond the expected, giving patients and providers more of what they need to thrive. Throughout their targeted drug delivery (TDD), infusion care, and ophthalmics divisions, they are committed to advancing quality and improving the lives of everyone they serve.
AKDYS partners with its clients, whether a product company, a CMO/CDMO or a VC/PE firm, to generate market and business intelligence data, business strategies, business plans, coach leaders and their teams and even develops board and investor relation presentation materials. They passionately support their clients in the transformation of their idea into a successful reality.
Aldevron is a leader in advancing biological science. Their custom development and manufacturing services have provided scientists around the world with the essential components to accelerate research and open up their laboratories for groundbreaking science and breakthrough discoveries.
Altis Biosystems was founded to address the biopharmaceutical industry's intense need for more accurate drug screening methods using in vitro platforms, which can more closely replicate human biology. Altis developed its intestinal platform to be the next generation for in vitro testing during drug development, allowing scientists to develop safer and more effective drugs using normal human intestinal tissue, and reducing the time and cost of drug discovery.
AMPAC has been producing high-quality specialty chemicals for over 60 years, principally oxidizers. Their primary product for the pharmaceutical market is sodium azide, which is designed to meet customer specifications and regulatory requirements. Their headquarters and state-of-the-art manufacturing facilities are located in Southern Utah.
Ampersand was founded in the late 1980s and began investing in healthcare in the early 1990s. Today, Ampersand is focused exclusively on growth equity investments in lower middle market healthcare companies. Typically, they are the first institutional investor in founder-owned businesses, where they work with the entrepreneur to help take the company to the next level.
A highly focused start-up in 2016, Argonaut has significantly expanded its services, capabilities and customer base in a very short period. Currently, they have 101,000+ square feet of manufacturing space and 150+ employees. Their services now include lyophilization, drug product manufacturing, and custom controls.
Asahi Kasei America, Inc. (AKA), established in 1971, is the North American Regional Administrative Office of Asahi Kasei Group. This company provides support for growth to North American group companies through administrative services including HR, IT, accounting, and IP as well as cross-sectional marketing activities. Along with its admin duties, AKA also operates the material businesses of Ceolus™, microcrystalline cellulose, and PIMEL™, photosensitive dielectric material.
BioAnalytix works with leading biotherapeutic companies in the development and application of advanced analytics and data analysis of complex biologics, from candidate selection through regulatory package development. Applying state of the art mass spectrometry, biophysical analytics, and method development expertise, our team of PhDs provides precise data packages for specific project needs through all stages of biotherapeutic drug development. We further offer our insights and understanding of CMC and regulatory requirements to support product development from IND through BLA.
BioLabs is the premier developer and operator of a network of hospitality-driven flexible laboratory co-working spaces for scientifically-based startups in established and emerging biotech clusters. These unique spaces are where innovation users come to test, develop and grow their game-changing ideas. As entrepreneurs and investors themselves, they have firsthand experience with the pain points biotech startups face. Their goal is to change how scientific entrepreneurs do business by building an ecosystem that empowers bioinnovators to grow quickly, while maximizing capital efficiency. BioLabs operates 10 sites in the US and has announced new sites in the US and Europe opening in 2022.
Breakthrough Marketing Technology is a business and strategic marketing consultancy serving clients looking to innovate and grow. They work across business sectors, leveraging a common set of unique tools, analytics, and processes to generate actionable insights, recommendations, and processes to improve business growth.
Burst Biologics is a registered tissue establishment and state-of-the-art manufacturing facility of HCT/P products. With a commitment to exceeding industry and regulatory standards, Burst Biologics maintains full control through careful procurement and extensive testing.
CAI is your global partner in providing professional services to enhance operational performance and reliability. The company brings top-tier expertise to every project stage, focusing on regulated manufacturing, mission-critical facilities, energy-efficient buildings, patient-critical facilities, and complex operations.
Calviri’s mission is to provide affordable products worldwide that will end deaths from cancer by combining a unique, highly immunogenic source of neoantigens with a peptide array platform. On the course to eradicate cancer, Calviri will develop new diagnostic and therapeutic products, and then preventative vaccines that will stop cancer from starting.
Canine Biologics wanted dogs to have an integrated approach to nutrition that would help them maintain their energy and stamina and continue to create great memories with their human families. So they set out to develop a complete and totally Integrated Nutrition System that can be utilized when their veterinarians believe they may greatly benefit from additional nutritional support.
CapSolutions provides a wide range of services to emerging pharmaceutical companies, contract manufacturing organizations, and venture capital firms. While their client mix is broad, their focus is on manufacturing Active Pharmaceutical Ingredients (API’s), their intermediates, and the services needed to support their manufacturing on a global basis.
Castleford Capital is a middle market private equity investment firm that brings more than just capital to its investments. With a concentrated focus on healthcare services, pharma services, and pharma products, Castleford is able to bring relevant expertise, networks, advisors, and personnel in support of the Company’s management team and implementation of the strategic vision.
The Chamber of Commerce for Greater Philadelphia, through its regional CEO Council for Growth, along with collaborating institutions, organizations and companies, has launched a multi-year initiative to leverage and promote Greater Philadelphia’s cell and gene therapy, gene editing, and connected health sectors. The objective of the Cell & Gene Therapy and Connected Health Initiative (The Initiative) is to strengthen the region’s innovation economy through efforts including shared storytelling that builds awareness of the region’s assets, providing resources to start-up and scaling companies, assessing the talent needs of the sectors, and supporting the development of critical infrastructure for the sectors’ growth. The Initiative is supported by 11 partner companies, institutions and universities in the Greater Philadelphia region. Partner companies include: AmerisourceBergen, Aramark, Children’s Hospital of Philadelphia, ChristianaCare, Comcast, Drexel University, Independence Blue Cross, Jefferson Health, Macquarie Group, Penn Medicine, and University of Pennsylvania.
With 90 sites around the globe, Charles River Laboratories is strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving their clients' product’s unique challenges. Their focus on timeliness and accuracy in every stage of development means their clients can count on reliable, reproducible results – every step of the way.
Chimeron Bio is building a portfolio of self-amplifying RNA therapeutics to bring more effective gene therapies and personalized medicines to patients. Their portfolio of innovative and personalized saRNA-based medicines is for people with serious diseases, including cancer, infectious diseases, and rare genetic disorders, using technology to achieve superior patient response at a lower dose.
Clene has a new vision for the future of pharmaceuticals. They are launching a new class of bioenergetic nanocatalysts that work in multiple cell types to improve several bioenergetic processes that may effectively treat many different diseases. This novel, wide-ranging approach represents a revolutionary shift in the pharmacological treatment of disease. Current Phase 2 studies include treatment of multiple sclerosis, Parkinson’s disease, and amyotrophic lateral sclerosis (Lou Gehrig’s disease)–neurodegenerative diseases with high unmet medical needs.
Commercial Healthcare Partners is dedicated to the creation of mutually beneficial partnerships within the pharmaceutical and biotechnology industries. Whether your organization has products, compounds, or technology to license out or is interested in acquiring such resources, Commercial Healthcare Partners can help.
CoreRx®, a contract development manufacturing organization (CDMO) with a focus on clinical phase drug product development, offers state-of-the-art facilities to support your supply chain needs throughout the entire clinical trial process. Their integrated offerings provide comprehensive services for developing, manufacturing, and testing solid, liquid, and semi-solid dosage forms.
Formerly AMRI, Curia is an end-to-end CDMO built to help pharmaceutical and biotech companies improve patients’ lives. They combine a flexible suite of R&D and manufacturing capabilities with industry-leading expertise to help partners accelerate the journey from idea to impact.
DEARhealth improves health outcomes and experiences while reducing costs by bundling the experience of expert medical specialists, nurses, scientists, and big-data analytics to continuously optimize care for complex, costly diseases.
DIANT Pharma was founded in 2019 and has developed a continuous processing technology applicable for nanoparticle drug products and vaccines. They strive to offer a technology that is robust and reliable from R&D to manufacturing; over a product’s lifespan. Their proprietary continuous manufacturing system for nanoparticles has a wide array of applications within the pharmaceutical space.
Edgewater Capital Partners is a private equity firm focused on four industry sectors: Specialty Industrials, Life Science, Advanced Materials, and Specialty Chemicals. Edgewater’s unique focus and deep expertise result in accelerated diligence and greater certainty to close, two things sellers consistently say is a signature of Edgewater.
With over 21 years and over 500 website projects experience, Efinitytech has devised a uniquely superior and effective method of developing and presenting website designs to clients. The company continues to grow, providing dynamic website designs, search engine optimization services, mobile website designs, application development, and expanded hosting services, all managed within our complete content management system.
Envisagenics is an Artificial Intelligence-driven, minority- and woman-led biotechnology company that focuses on the discovery of novel RNA splicing variants that cause cancer and other genetic diseases. Its principal technology is the SpliceCore® discovery platform. The platform re-envisions the human genome with a validated exon-centric approach, combined with machine learning algorithms and high-performance computing. It is up to 250 times more likely to discover novel targets than gene-centric discovery tools. Using innovative technology and RNA analysis expertise, Envisagenics accelerates the development of highly specific therapeutics that modulate RNA splicing variants that drive pathogenesis of oncology, neurodegenerative, and metabolic disorders.
Evonik’s Birmingham, Alabama, facility provides an integrated range of contract manufacturing services in support of projects from initial feasibility through commercial production of parenteral drug products and excipients including liquid, lyophilization, and powder filling aseptic capabilities. We are equipped with multiple cleanrooms, making it possible for us to provide an integrated range of services and technologies, including long acting injectables such as implants, micro- and nanoparticles, as well as lipid based delivery systems such as used for mRNA vaccines and therapies.
Excellere Partners is a private equity investment firm specializing in partnering with entrepreneurs and management teams – building enduring value with a spirit of partnership and excellence. The company assembled its proprietary capabilities to help managers confront the complexities of managing a rapidly growing business while maintaining the aggressive pursuit of their strategic vision.
Facible Biodiagnostics is a purpose-driven biodiagnostic technology company focused on helping people of all communities understand and optimize their health with a new hospital-grade fast track test that offers speed, accessibility, and accuracy. Their proprietary Quantum-Logic Anazyme Analyte Detection (Q-LAAD) technology gives fast, accurate and affordable hospital-grade diagnostic tests for decision makers to make treatment decisions.
ForDoz Pharma Co. is a privately-owned specialty pharmaceutical company focusing on the development, manufacturing, and commercialization of value-added sterile complex injectable products such as liposomes, microspheres, micelles, and nanosuspensions, microcrystal-suspensions, and more.
Forest Light Capital acquires and grows businesses in traditional industries with a proven track record of revenue and profits, stable cash flows, minimal debt, and a positive reputation in the market. They enjoy running and growing businesses and are committed to meeting (and exceeding) investor expectations.
Foster Delivery Science, Inc. focuses solely on Hot Melt Extrusion and extrusion processes to blend client API’s with polymers for several possible purposes: Solubility and bioavailability enhancement; create local delivery solutions such as drug loaded films, implants and fibers with extremely precise dose uniformity; create delivery or release profiles; and capture the powerful mixing capabilities of twin screw extruders. Operating from our new GMP facility 75 minutes from Boston in CT, we provide formulation development services, scale up, and GMP manufacturing for commercial and clinical trials.
Genesis AEC is an award-winning consulting, architecture, engineering, and construction management firm whose more than 25 years of experience complements clients' scientific expertise as they usher in the next generation of life-saving therapies, treatments, and technologies. With clients ranging from emerging start-ups to global leaders, they partner with life science organizations to conceive, build, and maintain compliant, efficient, and inspiring facilities.
Genoskin is a Partner Research Organization (PRO) with a unique expertise in skin & immunology that aims to disrupt drug development by changing the way to generate human data, enabling better, faster, safer drug development. Their proprietary ex vivo human skin platforms represent last-line screens, in laboratory conditions, prior to clinical evaluation. Their technologies only include natural human skin obtained from screenable patients cohort maintained in a living and functional state for several days.
Genscript is the world’s leading biotech company providing life sciences services and products. Genscript is internationally recognized as a leading biotech company specializing in fundamental life sciences research and early-phase drug discovery services with gene synthesis, peptide, protein, antibody, and preclinical drug development service capabilities. As of June 30, 2021, more than 64,700 peer-reviewed journal articles cited GenScript’s services and products, making GenScript the most frequently cited biotech company in the world.
Glacier Brewhouse is the gathering place for Anchorage dining, the smell of wood and the warmth of fires delight each guest. They are a popular and well-loved Anchorage restaurant and brewpub. Loyal followers have been around since 1996.
GT provides leading-edge, value-added solutions and results coaching to allow their customers to achieve their next breakthrough. Their multi-disciplinary team of subject matter experts from industry and academia uses a “Systems Engineering Point-of-View™” to arrive at solutions that manage, mitigate and balance budgetary, schedule, and technical risks.
Grand River Aseptic Manufacturing was founded in 2010 to support the life sciences industry’s growing need for high-quality, outsourced sterile injectable manufacturing. With over 100,000 square feet of sophisticated cGMP space, they meet a full range of fill and finish needs, from early clinical trial fills through commercialization.
Haematologic Technologies is a large molecule CRO unlike any other. Combining world-class protein chemistry expertise, integrated large molecule analytical services, and customized products to support biopharma R&D, Haematologic Technologies accelerate large molecule drug development for clients around the globe.
Heligenics believes that people can live healthier lives and that major healthcare problems can be solved through advanced analysis of the function of genetic variation. Heligenics is a life sciences company that has developed proprietary technology which shows the impact of genetic mutations to revolutionize genetic testing and drug development for major diseases.
H.I.G. Capital is a leading global alternative investment firm with $45 billion of equity capital under management, focusing on the small cap and mid cap segments of the market. The H.I.G. family of funds includes private equity, growth equity, real estate, debt/credit, lending, and biohealth.
iBio is pioneering the next generation of biologics leveraging the FastPharming System®, their proprietary plant-made pharmaceutical platform. Using plants as bioreactors for the production of recombinant proteins, FastPharming reduces development timelines, costs, and safety concerns that often accompany cell-based (animal, insect, microbial) protein expression methods.
The Icagen Ion Channel Technology Platform is a novel drug discovery platform that primarily uses ion channels and transporters. These are key components in a wide variety of biological processes that involve rapid changes in cells and potentially have broad therapeutic applicability, including cancer, metabolic disease, pain, neurological diseases, infectious diseases, and others.
Idaho Technology Council is a member-driven organization that includes partners ranging from growing companies, mid-size companies, and large corporations, all committed to the success of Idaho’s technology ecosystem. Through the leadership of this private sector, the ITC brings together industry, education, research, investment, and government throughout the state. The mission of the Idaho Technology Council is to help companies in Idaho start, grow, and thrive.
Headquartered in Redmond, Washington, USA, Inventprise is a biotechnology company specializing in GMP vaccine product development. Inventprise has a strong portfolio of patented technologies for conjugation chemistry and product stability, among others. They also undertake contract development, research and manufacturing. Inventprise was founded in 2012 by Dr. Subhash Kapre, whose five decades of executive experience in the vaccine field covered all aspects of development and manufacturing.
KCAS Bioanalytical and Biomarker Services, an Integris BioServices, LLC Company, provides comprehensive GLP / GCP compliant development services from early discovery support through product registration and beyond. The company provides a truly differentiated approach as one of only a select few CROs offering large and small molecule development with extensive capabilities and expertise to its clients looking for both scientific expertise and excellent customer service.
The KD Pharma Group specializes in creating custom products that address the multi-faceted needs of the global marketplace. The company employs a staff of industry-leading scientists using superior technology, as well as cutting-edge research and development to help accelerate your pharmaceutical and nutritional product development. This, combined with global support and unparalleled customer service, makes the KD Pharma Group your Partner in Creating Health Solutions.
Founded in February 2000, Key Corporate Services has established itself as a premier, niche recruiting firm focused in Pharmaceutical & Biotech, Industrial Chemicals, Food Ingredients, Manufacturing and Engineering, and Finance and Accounting. They help industry leading companies in these markets by identifying and guiding high-performing candidates to them for roles ranging from Business Development, Marketing, Corporate Executives (C-Suite), Manufacturing, Engineering, Regulatory Affairs, Quality Assurance and Finance.
Lonza provides life science researchers with the tools they need to develop and test therapeutics, from basic research to final product release. Their products and services range from cell culture and discovery technologies for research, to quality control tests and software for biomanufacturing.
LS Associates has a global service offering to provide on-demand C-Level leaders who can guide clients through every stage of growth or change management. LS Associates’ breadth of experience enables targeted, talented, and immediate leadership to clients to enable them to reach their strategic goals and milestones.
Madison Street Capital provides corporate financial advisory services, mergers and acquisitions expertise, valuation services and financial opinions to publicly and privately held businesses through our offices in North America, and Africa.
Mallinckrodt Pharmaceuticals is a multibillion-dollar specialty pharmaceutical company focused on providing medicines to address unmet patient needs. For more than 150 years, they have used their unique strengths, experience, and expertise to master and manage complexity to make high-quality products that provide value for patients. Mallinckrodt’s growing portfolio of specialty pharmaceuticals helps treat a wide variety of conditions, including autoimmune disorders and rare diseases in areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology, immunotherapy, neonatal respiratory critical care, analgesics, and gastrointestinal conditions.
Medgene Labs is a provider of world-class Immunological Services and Products including vaccines and monoclonal antibodies. Co-founded with world-renowned immunologist Dr. Alan Young, PhD, the Medgene Labs’ team has established an outstanding reputation for its data-driven approach.
Mikart is the comprehensive development and manufacturing organization (CDMO) that offers a broad range of capabilities including pharmaceutical drug development, clinical trial supplies, regulatory services, manufacturing, packaging and analytical services from early phase clinical development and manufacturing as well as a commercial for non-sterile solid oral and liquid oral dosage forms.
Montana Molecular’s fluorescent biosensors and BacMam viral vectors support the need for robust tools to assess clinically relevant biological activity in the context of live cell and animal models of disease. Most testing models measure a single step, at a single time point in a complex process. Montana Molecular’s biosensor products detect multiple responses in real time to capture biological effects in living cells, tissues and organisms. The company’s BacMam vector system optimizes delivery and expression in practically any cell type, and maintains consistency of expression in living cells.
Obatala is a New Orleans biotech company that offers research enabling products and brainpower to industry and academia to advance tissue engineering and regenerative medicine. A team of thought leaders, the company's goal is to promote diversity to advance the study and prevention of disease in obesity, diabetes, tissue engineering, and regenerative medicine.
ObvioHealth leverages digital and virtual technologies to make it easier to schedule, perform and track clinical assessments. Using pioneering technology to facilitate centralized virtual clinical trials, they accompany participants through every step of the journey to enroll them, help them complete tasks, and validate data capture. ObvioHealth works with sponsors from the outset, all the way through each study to design, run, analyze, and deliver successful trials.
OncoMyx believes that combination therapies are the path to the successful treatment of cancer. The goal at OncoMyx is to advance new oncolytic immunotherapies that improve the effectiveness of these therapies and expand their ability to help more cancer patients.
PhysIQ is laser focused on providing solutions that meet strict FDA requirements — all while pioneering the power of the IoT and expanding our transformational proprietary analytics, with the only FDA-cleared personalized analytics that learns a patient's baseline and detects subtle changes to provide unprecedented insight.
Established in 2018, Pluristyx Inc. is a privately held small business providing complete cell manufacturing solutions. As an advanced therapy tools company, Pluristyx helps both industrial and academic researchers solve manufacturing challenges in cryopreservation, drug development, regenerative medicine, and cell and gene therapy. The Pluristyx management team has decades of academic and industrial experience supporting every stage of cell therapy product development, from cell banking through the commercial manufacturing of clinical grade material as well as hands-on product and process development laboratory support.
Located in Suzhou, Porton Biologics Ltd. (Portonbio) was established in 2018. As a wholly-owned subsidiary of Porton Pharma Solutions Ltd, Portonbio is committed to providing end-to-end cell & gene therapy CDMO services for innovators from the early stage to commercial production.
Primal Therapies, Inc. is a biotechnology company founded in 2012 with a breakthrough approach to biofilm management. Leveraging their Selective Microbial Metabolism Regulation Technology (SMMRT) platform, they have developed a pipeline of proprietary formulas containing active ingredients that control the behavior of harmful bacteria. Their formulas can be used across industries as solutions solving problems associated with harmful and destructive biofilms.
Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s portfolio of over 4,000 products support a range of life science work across areas such as cell biology; DNA, RNA and protein analysis; drug development; human identification and molecular diagnostics. For over 40 years these tools and technologies have grown in their application and are used today by scientists and technicians in labs for academic and government research, forensics, pharmaceuticals, clinical diagnostics and agricultural and environmental testing.
Recipharm Recipharm is a leading CDMO headquartered in Stockholm, Sweden. They operate development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK, and the US and continues to expand. After 25 years of growth, Recipharm now employs approximately 9,000 people supporting pharmaceutical companies with their portfolio of full-service capabilities that take products from early development to commercial production. Recipharm conducts business as they always have and continues to deliver value for money, with each customer’s needs firmly at the heart of all they do.
As a leading premium-quality digital and offset printing company, RiverRun Press provides print and fulfillment solutions to customers ranging from small businesses and not-for-profits to large corporations. With multiple digital and traditional printing presses, their spectrum of capabilities encompasses simple, single-color projects through multi-color brochures, variable data applications, and across-the-board branding.
RoosterBio's vision is a world where safe and effective regenerative medicines are rapidly developed and widely available globally to benefit the lives of patients in need. RoosterBio solves regenerative medicine product and process development challenges with innovative biomanufacturing strategies, pairing an industrialized supply chain of high-quality hMSCs with productive bioprocess media and key process parameters.
Roswell Biotechnologies is digitizing biology through molecular electronics to elucidate, diagnose and treat disease. The company has developed the world's first molecular electronics chip, the Roswell ME Chip, by integrating single molecules into standard semiconductor chip technology to deliver a powerful biosensor that converges all omics on one platform.
SAB’s technology platform leverages the natural human immune response to develop next-generation, fully human polyclonal antibody therapeutics without the need for human serum, extending both the safety and potency. These highly-efficacious antibodies have proven to neutralize and block disease, and also address mutation. SAB’s platform represents, for the first time, the ability to produce targeted, fully human, high potency polyclonal therapies on a commercial scale.
Sable Systems International is the world leader for precision metabolic measurement, providing the tools, expertise, and training that enable scientific discovery, merging authoritative expertise in metabolic physiology and biophysics with an inventive spark to create precision tools for metabolic measurement, neurophysiology, and environmental science.
SCA Pharma is a nationally recognized leader in the FDA 503B outsourcing industry, specializing in providing the highest quality sterile admixture services and pre-filled syringes to hospital and healthcare facility pharmacies. The company serves all therapeutic areas of pharmacy — including critical care, labor and delivery, anesthesia, and pain management — and maintains a wide portfolio of products, including ready-to-use and drug-shortage medications.
Sinclair Research offers full-service IND-enabling toxicology and safety pharmacology services at a single research site. Whether your program is in late-stage discovery or entering clinical trials, Sinclair Research provides the services you need, the data you expect, and the customer service you deserve.
Solvias is a world leader in contract research, development and manufacturing (CRO/CDMO). They provide integrated analytical services and solutions to the pharmaceutical, biotech and medical device industries. Their comprehensive analytical testing portfolio integrates a broad range of capabilities spanning all stages of drug discovery, development and commercial release for better and safer products.
StageBio is the leading international provider of preclinical and clinical histology, pathology, image analysis, and specimen archiving services for the biopharmaceutical, medical device and contract research industries.
SPI Pharma's mission is to be a leading supplier of solutions to pharmaceutical formulation marketers worldwide. The primary objective is to engineer functional materials that enable customers to solve formulation problems, achieve differentiation, and gain speed to market. This is accomplished by establishing a leading position in functional materials and collaborating with customers to deliver value-added and cost-effective solutions to their problems.
Techceuticals provides process consulting and troubleshooting, training, equipment sourcing and many other services applicable to the pharmaceutical and dietary supplement manufacturing industries. Their wide range of services and processing expertise includes training programs, and hands-on training sessions, formulation development and assistance, non-GMP development space, quality systems, documentation processes and validation. Their services are available in small, hands-on training engagements through complete plant and operations engagements.
Tedor is a small customer-focused oral solid dose CDMO with a strong track record of meeting aggressive development and commercialization timelines for small to mid-size pharma companies. Over the past last 16 years has helped its customers receive many product approvals, including 10 in the last 3 years.
TeselaGen is deploying the first solution that incorporates state-of-the-art AI-enabled information technology for biotechnology as a secure enterprise operating system. TeselaGen makes the development of bio-based products faster and easier, providing a highly secure enterprise quality operating system that customers can use right away, instead of spending millions on developing it themselves.
Therachem is a full-service contract-based organization that supports early-stage and late-stage drug discovery and development and large-scale synthesis through their broad-based research solutions. At Therachem, the aim is to establish long-term, customer-focused partnerships with clients based on technical competence and trust.
Theraneutrics develops next-generation probiotic supplements that are designed to be affordable, accessible, and broadly effective. Their mission is to deliver science-based tools with proven effectiveness to improve physical health and wellbeing. Theraneutrics flagship product is Krystalase, a patent-pending probiotic supplement that is specifically engineered to solve gout.
TriRx Pharmaceutical Services is a CDMO committed to creating a better outsourcing experience for customers. They are currently offering R&D, manufacturing, packaging, and warehousing of sterile injectables, solid oral dose, soft chew, pastes and creams, non-sterile liquids, and semi-solids at its three facilities. Headquartered in Norwalk, Connecticut, their worldwide network of R&D and manufacturing facilities is rapidly expanding.
TwinStrand Biosciences is committed to applying a powerful new genomic technology across disciplines to improve human health and accelerate scientific discovery. The company's mission is to develop and deliver the unprecedented accuracy of Duplex Sequencing™ Technology to applications in clinical medicine and life sciences where it can do the greatest good for the greatest number of people.
As a frontrunner in the forest industry, UPM provides renewable solutions for various end uses, invests in sustainable growth, and innovates for a future beyond fossils. The company has responded to the growth in consumer demand with recyclable products made of responsibly sourced, renewable raw materials across six business areas: UPM Biorefining, UPM Energy, UPM Raflatac, UPM Specialty Papers, UPM Communication Papers, and UPM Plywood.
VIDA is modernizing lung care by integrating artificial intelligence from trials to treatment. VIDA modernizes lung and respiratory care, empowering healthcare organizations and physicians to improve patient outcomes, streamline care coordination, and drive efficiencies.
Viewpoint Molecular Targeting is a radiopharmaceutical company developing precision oncology therapeutics and complementary diagnostic imaging agents. Viewpoint’s leading lead-212-based alpha-particle radiotherapies are designed to deliver powerful alpha radiation specifically to cancer cells utilizing specialized targeting peptides. Viewpoint is also developing complementary imaging diagnostics that utilize the same targeting peptide to personalize treatment and optimize patient outcomes.
Waters Corporation is a leading technology company delivering scientific insights to improve human health and well-being. For more than 60 years, Waters has been helping customers in the life, materials, and food sciences make scientific ambitions a reality through the application of liquid chromatography, mass spectrometry, and thermal analysis innovations. Together, they ensure the safety and efficacy of medicines, the purity of food and water, and the quality of products used every day.
Wheeler Bio is a biomanufacturing company designed to accelerate the translation of therapeutic innovation into clinical impact. Through parallel integration with pre-clinical discovery, Wheeler is democratizing access to comprehensive discovery-to-IND programs with its rapid, high-quality biomanufacturing and portable CMC platform. With an initial focus on antibody therapeutics, the company offers emerging biopharma companies a faster and more predictable path to the clinic by avoiding the critical gaps between discovery and early development.
Grace is a global leader in specialty chemicals and materials. Grace Materials Technologies (MT) delivers silica-based materials to world-class companies to improve their products and processes in general industrial, pharmaceutical/nutraceutical, coatings, consumer, personal care, food/beverage, cosmetics, and plastics industries. The MT division also encompasses Grace’s Fine Chemical Manufacturing Services (FCMS) group, a leading CDMO in North America with complementary expertise at three facilities from coast to coast supporting customized development of APIs, cGMP intermediates, and RSMs.
Yourway is an integrated biopharmaceutical supply chain solutions provider offering a full range of primary and secondary clinical packaging, temperature-controlled logistics, storage, and distribution services for the global pharmaceutical and biotech industries. Headquartered in Pennsylvania, with 20 additional strategic locations worldwide, Yourway specializes in time- and temperature-sensitive clinical drug product and biological sample shipments.
Zavation designs, develops, manufactures, and distributes medical device products that provide comprehensive medical solutions to help surgeons treat patients around the world.
Zhittya Genesis Medicine (ZGM) is a Biopharmaceutical company advancing a group of drugs which trigger the human body’s natural regeneration process. Zhittya’s regenerative drugs act by specifically stimulating the growth of new blood vessels (a biological process termed “angiogenesis”) in tissues or organs that have perfusion defects.